A series of two classes of 3-phenylpyrazolopyrimidine-1, 2, 3-triazole conjugates were synthesized using click chemistry approach. All compounds were evaluated for inhibition of Src kinase and human ovarian adenocarcinoma (SK-Ov-3), breast carcinoma (MDA-MB- 361), and colon adenocarcinoma (HT-29). Hexyl triazolyl-substituted 3- phenylpyrazolopyrimidine exhibited inhibition of Src kinase with an IC50 value of 5.6 μM. ...